Change of coagulation system after cardiac implantable electronic device implantation

Change of coagulation system after cardiac implantable electronic device implantation - Change of coagulation system after cardiac implantable electronic device implantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009645

Enrollment

Registered

2012-12-27

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arrhythmia, heart failure

Interventions

Implantation or exchange of pacemaker, implantable cardiac defibrillator, or cardiac resynchronization therapy devices.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with bradycardia , tachyarrhythmia, or heart failure who need to implant cardiac implantable electronic devices. 2) Admitted patients 3) Patients with informed consent in paper

Exclusion criteria

Exclusion criteria: 1) Needs to continue anticoagulation therapy 2) Judged inappropriated patients by Doctor

Design outcomes

Primary

Measure	Time frame
Value of coagulation and fibrinolytic systems before and after device implantation	—

Countries

Japan

Contacts

Public ContactMasayuki Takamura

Kanazawa University Department of Disease Control and Homeostasis

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026